Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis

BACKGROUND: Currently, clinical studies on the prognosis of prostate cancer (PC) taking aspirin were developing, but the precise mechanism of aspirin on tumor cells was still unclear. In addition, the conclusion that aspirin can improve the prognosis of PC patients continues to be controversial. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiatong, Xia, Shuai, Li, Tao, Liu, Ranlu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894469/
https://www.ncbi.nlm.nih.gov/pubmed/31805980
http://dx.doi.org/10.1186/s12885-019-6415-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894469/
https://www.ncbi.nlm.nih.gov/pubmed/31805980
http://dx.doi.org/10.1186/s12885-019-6415-5

Ejemplares similares